Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
出版年份 2015 全文链接
标题
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
作者
关键词
-
出版物
CANCER
Volume 122, Issue 4, Pages 588-597
出版商
Wiley
发表日期
2015-11-14
DOI
10.1002/cncr.29783
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
- (2015) Herbert I. Hurwitz et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Smac mimetics as IAP antagonists
- (2015) Simone Fulda SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells
- (2014) Aiping Tian et al. CANCER LETTERS
- Combination effects of SMAC mimetic birinapant with TNFα, TRAIL, and docetaxel in preclinical models of HNSCC
- (2014) Danielle F. Eytan et al. LARYNGOSCOPE
- Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF- B Activation, and Is Active in Patient-Derived Xenograft Models
- (2014) C. A. Benetatos et al. MOLECULAR CANCER THERAPEUTICS
- Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system
- (2013) Jin-Qiu Chen et al. ANALYTICAL BIOCHEMISTRY
- The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
- (2013) C. Krepler et al. CLINICAL CANCER RESEARCH
- Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL)
- (2013) Cinzia Scavullo et al. LEUKEMIA RESEARCH
- Capillary Isoelectric-Focusing Immunoassays to Study Dynamic Oncoprotein Phosphorylation and Drug Response to Targeted Therapies in Non–Small Cell Lung Cancer
- (2013) Jin-Qiu Chen et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Activity of a Novel Homodimeric SMAC Mimetic in Ovarian Carcinoma
- (2013) Laura Gatti et al. MOLECULAR PHARMACEUTICS
- Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
- (2012) James W. Antoon et al. Scientific Reports
- Activation of NF- B Signaling by Inhibitor of NF- B Kinase Increases Aggressiveness of Ovarian Cancer
- (2010) L. Hernandez et al. CANCER RESEARCH
- Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: A Gynecologic Oncology Group study
- (2010) Peter G. Rose et al. GYNECOLOGIC ONCOLOGY
- Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens
- (2009) Alice C Fan et al. NATURE MEDICINE
- Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics
- (2008) Haiying Sun et al. ACCOUNTS OF CHEMICAL RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation
- (2008) Eugene Varfolomeev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More